Try our corporate solution for free!
(212) 419-8286

Biotech firms active in COVID-19 R&D in Italy 2020, by product

According to a survey conducted in May 2020 in Italy, nearly 57 percent of biotech companies in the country were taking part in research and development (R&D) or production activities in the fight against the novel coronavirus disease (COVID-19). Of the 57 percent active in this effort, 44 percent were operating in the diagnostics segment, while seven percent were taking part in the race for a vaccine.

Share of biotech companies in Italy active in COVID-19 R&D as of May 2020, by product type

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

May 2020



Survey time period

May 2020

Special properties

biotech companies involved in COVID-19 R&D

Supplementary notes

The source does not provide information about the methodology and date of the survey.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Italy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.